Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Mayhew Jonathan E.

2. Date of Event Requiring Statement (MM/DD/YYYY) 3/11/2020

3. Issuer Name and Ticker or Trading Symbol

CVS HEALTH Corp [CVS]

(Last) (First) (Middle)

ONE CVS DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
EVP, Chief Transformation Off /

(Street)

WOONSOCKET, RI 02895

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	13537	D
Common Stock (restricted)	10057 ⁽¹⁾	D
Common Stock (restricted)	3049 ⁽²⁾	D
CVS Health Future Fund 401(k) Common Stock	408.3167	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Appreciation Rights	⁽³⁾	2/18/2026	Common Stock	6634	$37.91	D
Stock Appreciation Rights	⁽⁴⁾	2/16/2027	Common Stock	11333	$45.91	D
Stock Appreciation Rights	⁽⁵⁾	5/9/2027	Common Stock	3067	$52.42	D
Stock Option	⁽⁶⁾	4/1/2029	Common Stock	44037	$54.19	D

Explanation of Responses:
(1)	Consists of Restricted Stock Units ("RSUs") awarded pursuant to Issuer's Aetna Inc. 2010 Stock Incentive Plan (the "Aetna Plan"). Restrictions lapse in four equal annual installments, commencing on 4/1/2020.
(2)	Consists of Issuer RSUs that were converted, pursuant to the CVS-Aetna Merger Agreement dated December 3, 2017 (the "Merger Agreement"), from Aetna Performance Stock Units ("PSUs") granted under the Aetna Plan, and that vest on 12/2/2020.
(3)	Stock Appreciation Rights ("SARs") granted under the Aetna Plan and converted pursuant to the Merger Agreement, that became exercisable on 2/19/2019.
(4)	SARs granted under the Aetna Plan and converted pursuant to the Merger Agreement, that became exercisable in two equal installments, commencing on 2/17/2019.
(5)	SARs granted under the Aetna Plan and converted pursuant to the Merger Agreement, that became exercisable in two equal annual installments, commencing on 5/10/2019.
(6)	Stock options that become exercisable in four equal annual installments, commencing 4/1/2020.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Mayhew Jonathan E. ONE CVS DRIVE WOONSOCKET, RI 02895			EVP, Chief Transformation Off